BarrW. H.PennaR. P.: Internal Analgesics, Handbook of Non-Prescription Drugs, American Pharmaceutical Association, p. 36, 1973.
2.
ibid p. 42.
3.
ScottT. J.: Studies of Gastrointestinal Bleeding Caused by Corticosteroids, Salicylates and Other Analgesics, Quart. J. Med.20: 167, 1961.
4.
DavenportH. W.: Gastric Mucosal Injury by Fatty and Acetylsalicylic Acid, Gastroenterology46: 245, 1964.
5.
DavenportH. W.: Damage to the Gastric Mucosa: Effects of Salicylates and Stimulation, Gastroenterology49: 189, 1965.
6.
DavenportH. W.: Fluid Produced by the Gastric Mucosa During Damage by Acetic and Salicylic Acids, Gastroenterology50: 487, 1966.
7.
DavenportH. W.: Salicylate Damage to the Gastric Mucosal Barrier, New Engl. J. Med.276: 1307, 1967.
8.
MartinB. K.: “Discussion” in DixonA. St. J.MartinB. K.SmithM. J. H.WoodP. H. N. eds., Salicylates, An International Symposium, Little, Brown, Boston, p. 209, 1963.
9.
LeonardsJ. R.LevyG.: Reduction or Prevention of Aspirin-Induced Occult Gastrointestinal Blood Loos in Man, Clin. Pharmacol. Ther.10: 571, 1969.
10.
HirschmanJ. L.: The D.I.A.S. Rounds, Drug Intell. Clin. Pharm.4: 309, 1970.
11.
AlvarezA. S.SummerskillW. H. J.: Gastrointestinal Hemorrhage and Salicylates, Lancet275: 920, 1958.
12.
HirschmanJ. L.: The D.I.A.S. Rounds, Drug Intell. Clin. Pharm.4: 309, 1970.
13.
ibid p. 308.
14.
HirschowitzB. I.: The Action of Ethyl Alcohol on Gastric Acid Secretion, Gastroenterology30: 244, 1956.
15.
GoulstonK.CookeA. R.: Alcohol, Aspirin, and Gastrointestinal Bleeding, Brit. Med. J.664, 1968.
16.
GoodmanL. S.GilmanA. eds.: The Pharmacological Basis of Therapeutics, Fourth ed., MacMillan, New York, p. 338, 1970.
17.
ibid p. 337.
18.
DavisP. S.DellerD. J.: Salicylates and Iron Absorption, Gastroenterology52: 691, 1967.
19.
LevyG.ReuningR. H.: Effect of Complex Formation on Drug Absorption I: Complexes of Salicylic Acid with Absorbable and Non-Absorbable Compounds, J. Pharm. Sci.53: 1471, 1964.
20.
JeremyR.TowsonJ.: Interaction Between Aspirin and Indomethacin in the Treatment of Rheumatoid Arthritis, Med. J. Aust.2: 127, 1970.
21.
ChampionG. D.: The Effect of Aspirin on Serum Indomethacin, Clin. Pharmacol. Ther.13: 239, 1972.
22.
YuT. F.: Mutual Suppression of the Uriocosuric Effects of Sulfinpyrazone and Salicylate: A Study in Interactions Between Drugs, J. Clin. Invest.42: 1330, 1963.
23.
BaylesT. B.: Plasma Salicylate Levels in Rheumatoid Arthritis, in DixonA. St. J.MartinB. K.SmithM. J. H.WoodP. H. N. eds., Salicylates, An International Symposium, Little, Brown, Boston, p. 43, 1963.
24.
SmithM. J. H.SmithP. K.: The Salicylates, Interscience Publishers, New York, p. 36–37, 1966.
OdellG. B.: Studies in Kernicterus. The Protein Binding of Bilirubin, J. Clin. Invest.38: 823, 1959.
27.
SmithM. J. H.SmithP. K.: The Salicylates, Interscience Publishers, New York, p. 72, 1966.
28.
ManchesterK. L.RandleP. J.SmithG. H.: Some Effects of Sodium Salicylate on Muscle Metabolism, Brit. Med. J.1958I: 1028, 1958.
29.
KendallM. J.: Xylose Test: Effect of Aspirin and Indomethacin, Brit. Med. J.1971I: 533, 1971.
30.
HechtA.GoldnerM. G.: Reappraisal of the Hypoglycemic Action of Acetylsalicylate, Metabolism8: 418, 1959.
31.
StowersJ. M.: Clinical and Pharmacological Comparison of Chlorpropamide and Other Sulfonylureas, Ann. N. Y. Acad. Sci.74: 689, 1959.
32.
WishinskyH.: Protein Interactions of Sulfonylurea Compounds, Diabetes2: 18, 1962.
33.
BergmanH.: Hypoglycemic Coma During Sulfonylurea Therapy, Acta Med. Scand.177: 287, 1965.
34.
PeastonM. J. T.FinneganP.: A Case of Combined Poisoning with Chlorpropamide, Acetylsalicylic Acid, and Paracetamol, Brit. J. Clin. Pract.22: 30, 1968.
35.
DixonR. L.: Plasma Protein Binding of Methotrexate and its Displacement by Various Drugs, Fed. Proc.24: 454, 1965.
36.
LieglerD. G.: The Effect of Organic Acids on Renal Clearance of Methotrexate in Man, Clin. Pharmacol. Ther.134: 291, 1961.
37.
DubinH. V.HarrellE. R.: Liver Disease Associated with Methotrexate Treatment of Psoriatic Patients, Arch. Dermatol.102: 498, 1970.
38.
BakerH.: Intermittent High Dose Oral Methotrexate in Psoriasis, Brit. J. Dermatol.82: 65, 1970.
39.
AntonA. H.: A Drug-Induced Change in the Distribution and Renal Excretion of Sulfonamides, J. Pharmacol. Exp. Ther.134: 291, 1961.
40.
AntonA. H.: Increasing Activity of Sulfonamides with Displacing Agents: A review, Ann. N. Y. Acad. Sci.226: 273, 1973.
41.
KuninC. M.: Enhancement of Antimicrobial Activity of Penicillins and Other Antibiotics in Human Serum by Competitive Serum Binding Inhibitors, Proc. Soc. Exptl. Biol. N. Y.117: 69, 1964.
42.
SmithM. J. H.SmithP. K.: The Salicylates, Interscience Publishers, New York, p. 237–243, 1966.
43.
HoltP. R.: Measurement of Gastrointestinal Blood Loss in Subjects Taking Aspirin, J. Lab. Clin. Med.56: 717, 1960.
44.
ScottT. J.: Studies of Gastrointestinal Bleeding Caused by Corticosteroids, Salicylates and Other Analgesics, Quart. J. Med.30: 167, 1961.
45.
WoodP. H. N.: Studies of Occult Bleeding Caused by Salicylates and Related Compounds, in DixonA. St. J.MartinB. K.SmithM. J. H.WoodP. H. N. eds., Salicylates. An International Symposium, Little, Brown, Boston, p. 194–198, 1963.
46.
PiersonR. N.HoltP. R.WatsonR. M.KeatingR. P.: Aspirin and Gastrointestinal Bleeding, Amer. J. Med.31: 259, 1961.
47.
SchneiderE. M.: Aspirin as a Gastric Irritant;Gastroenterology33: 616, 1957.
48.
MeyerO. O.HowardB.: Production of Hypo-prothrombinemia and Hypocoagulatability of the Blood with Salicylates, Proc. Soc. Exp. Biol. Med.53: 234, 1943.
49.
QuickA. J.ClesceriL.: Influence of Acetylsalicylic Acid and Salicylamide on the Coagulation of Blood, J. Pharmacol. Exp. Ther.128: 95, 1960.
50.
GoodmanL. S.GilmanA. eds.: The Pharmacological Basis of Therapeutics, FourthE., MacMillan, New York, p. 320, 1970.
51.
WatsonR. M.PiersonR. N.: Effect of Anticoagulant Therapy Upon Aspirin-Induced Gastrointestinal Bleeding, Circulation24: 613, 1961.
52.
UdallJ. A.: Drug Interference with Warfarin Theapy, Clin. Med.77: 20, 1970.
53.
O'ReillyR. A.AggelerP. M.: Determinants of the Response to Oral Anticoagulant Drugs in Man, Pharmacol. Rev.22: 35, 1970.
54.
KaneshiroM. M.: Bleeding Time After Aspirin in Disorders of Intrinsic Clotting, N. Engl. J. Med.281: 1039 (Nov. 6) 1969.
55.
WoodL.: Treatment of Atherosclerosis and Thrombosis with Aspirin, Lancet19722: 532, 1972.
56.
GirominiM.: Effect of Dipyridamole and Aspirin in Thrombotic Microangiopathy, Brit. Med. J.19721: 545, 1972.
57.
GoodmanL. S.GilmanA. eds.: The Pharmacolgical Basis of Therapeutics, Fourth ed., MacMillan, New York, pp. 264–316, 1970.
58.
LucasB. G.: Dilantin Overdosage, Med. J. Aust.55: 639, 1968.
59.
ClarkT. H.: Drug Interactions That Can Affect Your Patients, Patient Care1: 33, 1967.
60.
KlinenbergJ. R.MillerF.: Effect of Corticosteroids on Blood Salicylate Concentration, J. Amer. Med. Assoc.194: 601, 1965.
61.
HuangC. L.HiranoK.: The Effect of Antipyretic Analgesics on the Metabolism of Chlorpromazine in Man, Biochem. Pharmacol.16: 2023, 1967.
62.
FennessyM. R.RaperC.: Interactions of Methocarbamol with Morphine and Aspirin, J. Pharm. Pharmacol.21: 873, 1969.
63.
SalassaR. M.BollmanJ. L.DryT. J.: The Effect of Para-aminobenzoic Acid on the Metabolism and Excretion of Salicylates, J. Lab. Clin. Med.33: 1393, 1948.
64.
YaffeS. J.: Enhancement of Glucuronide-Conjugating Capacity in a Hyperbilirubinemic Infant Due to Apparent Enzyme Induction by PhenobarbitalN. Engl. J. Med.275: 1461, 1966.
65.
YuT. F.: Mutual Suppression of the Uricosuric Effects of Sulfinpyrazone and Salicylate: A Study in Interactions Between Drugs, J. Clin. Invest.42: 1330, 1963.
66.
YuT. F.: Interactions of Salicylate and Sulfinpyrazone in Man, Fed. Proc.21: 175, 1962.
67.
PascaleL. R.: Inhibition of the Uricosuric Action of Benemid by Salicylate, J. Lab. Clin. Med.45: 771, 1955.
68.
OyerJ. H.: Suppression of Salicylate-Induced Uricosuria by Phenylbutazone, Amer. J. Med. Sci.251: 11966.
69.
ElliottH. C.: Salicylates: Metabolism and Biochemical Effects: a Review, Alabama J. Med. Sci.1: 38, 1964.
70.
HoffmanL. M.: Interaction of Spironolactone and Hydrochlorothiazide with Aspirin in the Rat and the Dog, J. Pharmacol. Exp. Ther.180: 1, 1972.
71.
TweeddaleM. G.OgilvieR. I.: Antagonism of Spironolactone Induced Natriuresis by Aspirin in Man, N. Engl. J. Med.289: 198, 1971.
72.
LevyG.LeonardsJ. R.: Urine pH and Salicylate Therapy, J. Amer. Med. Assoc.217: 81, 1971.